Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Cipla Medpro (Pty) Ltd., Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA Customer care: 080 222 6662
MUCOSOLV CAPSULES is indicated as adjunctive therapy in respiratory tract disorders characterised by excessive viscous mucous in the absence of infection.
Take two (2) capsules three (3) times daily, reducing to one (1) capsule four (4) times daily when a satisfactory response has been obtained.
MUCOSOLV CAPSULES are for oral use only.
Gastrointestinal disturbance is the most likely symptom of MUCOSOLV CAPSULES overdosage.
36 months.
Store at or below 25°C.
MUCOSOLV CAPSULES are orange/white hard gelatine capsules.
MUCOSOLV CAPSULES are packed in blister strips of 10 capsules packed in cartons of 30 or 100 capsules per carton.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
